Skip to content
AwardedSpainGoodsFramework agreement

ACUERDO MARCO DE SUMINISTRO DE MEDICAMENTOS ONCOLÓGICOS

Published
Published 15 July 2026

Overview

Framework agreement for the supply of oncological medications awarded on 14 July 2026 to eight pharmaceutical suppliers: Alexion Pharma Spain, Baxter, Daiichi Sankyo España, Janssen-Cilag, Laboratorios Servier, Menarini Stemline España, Roche Farma, and one additional supplier. The Consorci de Salut i d'Atenció Social de Catalunya procures cancer treatment medicines under this multi-supplier framework arrangement.

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Direct
Contract type
Framework agreement
Published
15 July 2026
Classification (CPV)
Various medicinal products

Award outcome

Awarded value
€0
Award date
14 July 2026
Winners
  • ALEXION PHARMA SPAIN SLU
  • BAXTER SL
  • DAIICHI SANKYO ESPAÑA, S.A.
  • JANSSEN-CILAG, S.A.
  • LABORATORIOS SERVIER S.L.
  • MENARINI STEMLINE ESPAÑA, S.L.U
  • ROCHE FARMA, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    15 July 2026

Contracting authority

  • Consorci de Salut i d'Atenció Social de Catalunya

    Procuring entity

    No consta, Spain

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: ACUERDO MARCO DE SUMINISTRO DE MEDICAMENTOS ONCOLÓGICOS — won by ALEXION PHARMA SPAIN SLU +6 — Skim